+

WO1992012134A3 - Certains derives de phenylimidazole aminomethyle; nouvelle classe de ligands a specificite de sous-type de recepteur de dopamine - Google Patents

Certains derives de phenylimidazole aminomethyle; nouvelle classe de ligands a specificite de sous-type de recepteur de dopamine Download PDF

Info

Publication number
WO1992012134A3
WO1992012134A3 PCT/US1991/009816 US9109816W WO9212134A3 WO 1992012134 A3 WO1992012134 A3 WO 1992012134A3 US 9109816 W US9109816 W US 9109816W WO 9212134 A3 WO9212134 A3 WO 9212134A3
Authority
WO
WIPO (PCT)
Prior art keywords
dopamine receptor
new class
receptor subtype
specific ligands
subtype specific
Prior art date
Application number
PCT/US1991/009816
Other languages
English (en)
Other versions
WO1992012134A2 (fr
Inventor
Andrew Y Thurkauf
Alan J Hutchison
Original Assignee
Neurogen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurogen Corp filed Critical Neurogen Corp
Priority to US08/081,317 priority Critical patent/US5428164A/en
Priority to EP92903112A priority patent/EP0640075A1/fr
Priority to CA002098301A priority patent/CA2098301C/fr
Publication of WO1992012134A2 publication Critical patent/WO1992012134A2/fr
Publication of WO1992012134A3 publication Critical patent/WO1992012134A3/fr
Priority to US08/461,135 priority patent/US5646281A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Cette invention concerne des composés de la formule (I) dans laquelle R1, R3, R4, R6, X, Y et Z et T représentent des variables; et M représente α ou β, où R2 représente une variable; ou R1 et R2 peuvent représenter ensemble -(CH2)n1 dans lequel n1 représente 1, 2 ou 3. Ces composés sont des antagonistes ou des agonistes partiels très sélectifs pour des sous-types de récepteur de dopamine du cerveau ou des promédicaments, de ces derniers, et sont utiles pour diagnostiquer et traiter des désordres affectifs tels que la schizophrénie et la dépression ainsi que certains troubles moteurs tels que la maladie de Parkinson. En outre, les composés de cette invention peuvent être utiles pour traiter les effets secondaires provoqués par l'extraparamidyle, associés à l'utilisation d'agents neuroleptiques classiques.
PCT/US1991/009816 1990-12-28 1991-12-23 Certains derives de phenylimidazole aminomethyle; nouvelle classe de ligands a specificite de sous-type de recepteur de dopamine WO1992012134A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US08/081,317 US5428164A (en) 1990-12-28 1991-12-23 Certain 4-aryl substituted piperazinyl and piperidinylmethyl phenylimidazole derivatives; a new class of dopamine receptor subtype specific ligands
EP92903112A EP0640075A1 (fr) 1990-12-28 1991-12-23 Certains derives de phenylimidazole aminomethyle; nouvelle classe de ligands a specificite de sous-type de recepteur de dopamine
CA002098301A CA2098301C (fr) 1990-12-28 1991-12-23 Certains derives aminomethylphenylimidazole; une nouvelle categorie de ligands specifiques d'un sous-type de recepteur de la dopamine
US08/461,135 US5646281A (en) 1990-12-28 1995-06-05 Certain 4-piperidino- and piperazinomethyl-2-phenyl imidazole derivatives; dopamine receptor subtype specific ligands

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/635,256 US5159083A (en) 1990-12-28 1990-12-28 Certain aminomethyl phenylimidazole derivatives; a class of dopamine receptor subtype specific ligands
US635,256 1990-12-28

Publications (2)

Publication Number Publication Date
WO1992012134A2 WO1992012134A2 (fr) 1992-07-23
WO1992012134A3 true WO1992012134A3 (fr) 1992-08-20

Family

ID=24547067

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1991/009816 WO1992012134A2 (fr) 1990-12-28 1991-12-23 Certains derives de phenylimidazole aminomethyle; nouvelle classe de ligands a specificite de sous-type de recepteur de dopamine

Country Status (6)

Country Link
US (2) US5159083A (fr)
EP (1) EP0640075A1 (fr)
JP (1) JP2798095B2 (fr)
BR (1) BR1100956A (fr)
CA (1) CA2098301C (fr)
WO (1) WO1992012134A2 (fr)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ238688A (en) * 1990-06-28 1992-05-26 Smithkline Beecham Corp Substituted histidines: pharmaceutical compositions, preparation and uses thereof
US5633376A (en) * 1990-12-28 1997-05-27 Neurogen Corporation Certain aminomethyl phenylimidazole derivatives; and 4-aryl substituted piperazinyl and piperidinylmethyl phenylimidazole derivatives; a new class of dopamine receptor subtype ligands
US5681956A (en) * 1990-12-28 1997-10-28 Neurogen Corporation 4-aryl substituted piperazinylmethyl phenylimidazole derivatives; a new class of dopamine receptor subtype specific ligands
US5646281A (en) * 1990-12-28 1997-07-08 Neurogen Corporation Certain 4-piperidino- and piperazinomethyl-2-phenyl imidazole derivatives; dopamine receptor subtype specific ligands
US5646279A (en) * 1990-12-28 1997-07-08 Neurogen Corporation Substituted 4-piperazinylmethyl 2-phenylimidazoles; dopamine receptor subtype specific ligands
US5159083A (en) * 1990-12-28 1992-10-27 Neurogen Corporation Certain aminomethyl phenylimidazole derivatives; a class of dopamine receptor subtype specific ligands
US5414010A (en) * 1994-05-10 1995-05-09 Warner-Lambert Company Dimeric benzimidazoles as central nervous system agents
US5922751A (en) * 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
WO1996016040A1 (fr) * 1994-11-23 1996-05-30 Neurogen Corporation Certains derives 4-aminomethyl 2-substitues de l'imidazole et derives 2-aminomethyl 4-substitues de l'imidazole, nouvelles categories de ligands specifiques du sous-type du recepteur de la dopamine
US5478934A (en) * 1994-11-23 1995-12-26 Yuan; Jun Certain 1-substituted aminomethyl imidazole and pyrrole derivatives: novel dopamine receptor subtype specific ligands
WO1996016057A1 (fr) * 1994-11-23 1996-05-30 Neurogen Corporation Certains derives d'aminoethyl imidazole et pyrrole substitues en 1; nouveaux ligands specifiques d'un sous-type de recepteur dopaminergique
US5856326A (en) * 1995-03-29 1999-01-05 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
IL117580A0 (en) * 1995-03-29 1996-07-23 Merck & Co Inc Inhibitors of farnesyl-protein transferase and pharmaceutical compositions containing them
AU5982696A (en) * 1995-06-05 1996-12-24 Neurogen Corporation 1-(n'-(arylalkylaminoalkyl)) aminoisoindoles as dopamine rec eptor ligands
US5872136A (en) * 1996-04-03 1999-02-16 Merck & Co., Inc. Arylheteroaryl inhibitors of farnesyl-protein transferase
US6001835A (en) * 1996-04-03 1999-12-14 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
CA2249605A1 (fr) * 1996-04-03 1997-10-09 Merck & Co., Inc. Inhibiteurs de transferase de farnesyl-proteine
CA2249650A1 (fr) * 1996-04-03 1997-10-09 Merck & Co., Inc. Inhibiteurs de la farnesyl-proteine transferase
US5883105A (en) * 1996-04-03 1999-03-16 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US5891889A (en) * 1996-04-03 1999-04-06 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
AU706150B2 (en) * 1996-04-03 1999-06-10 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
EP0891356A1 (fr) * 1996-04-03 1999-01-20 Merck & Co., Inc. Inhibiteurs de la farnesyl-proteine transferase
US5965578A (en) * 1996-04-03 1999-10-12 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US5869682A (en) * 1996-04-03 1999-02-09 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
JP2000507595A (ja) * 1996-04-03 2000-06-20 メルク エンド カンパニー インコーポレーテッド ファルネシルプロテイントランスフェラーゼの阻害剤
US5905152A (en) * 1996-08-08 1999-05-18 Schering Corporation Preparation of aminomethyl-phenylimidazoles
US5939439A (en) * 1996-12-30 1999-08-17 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US6093737A (en) * 1996-12-30 2000-07-25 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US5922715A (en) * 1997-02-18 1999-07-13 American Home Products Corporation 5-aminoalkoxy-1, 4-dihydroquinoxaline-2, 3-diones
JP2001511805A (ja) * 1997-02-18 2001-08-14 アメリカン・ホーム・プロダクツ・コーポレイション ドパミン作動薬である５−アミノアルコキシ−１，４−ジヒドロキノキサリン−２，３−ジオン
US5972942A (en) * 1997-03-27 1999-10-26 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US6127390A (en) * 1997-10-02 2000-10-03 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
US6031097A (en) 1997-10-27 2000-02-29 Neurogen Corporation 1-(N-(arylalkylaminoalkyl) aminoisoquinolines; a new class of dopamine receptor subtype specific ligands
AU1122399A (en) * 1997-10-27 1999-05-17 Neurogen Corporation Novel 1-(n'-(arylalkylaminoalkyl))aminoisoindoles; a new class of dopamine receptor subtype specific ligands
US6166205A (en) * 1998-09-02 2000-12-26 Neurogen Corporation 2-Aryl-4-(1-[4-heteroaryl]piperazin-1-yl)methylimidazoles: dopamine . D.sub4 receptor subtype ligands
WO2000018763A2 (fr) * 1998-09-29 2000-04-06 Neurogen Corporation 2-(2,3-dihydrobenzofuran-5-yl)-4-aminomethylimidazoles; ligands specifiques du sous-type du recepteur de dopamine
US6288230B1 (en) 1998-09-29 2001-09-11 Neurogen Corporation 2-(2, 3-dihydrobenzofuran-5-yl)-4-aminomethylimidazoles: dopamine receptor subtype specific ligands
US6284759B1 (en) 1998-09-30 2001-09-04 Neurogen Corporation 2-piperazinoalkylaminobenzo-azole derivatives: dopamine receptor subtype specific ligands
US6723743B1 (en) * 1999-09-28 2004-04-20 Neurogen Corporation High affinity small molecule C5a receptor modulators
US6884815B1 (en) * 1999-09-28 2005-04-26 Neurogen Corporation High affinity small molecule C5a receptor modulators
EP1322309B1 (fr) * 2000-09-29 2008-08-13 Neurogen Corporation Petites molecules modulatrices des recepteurs c5a a haute affinite
JP2005528368A (ja) 2002-03-29 2005-09-22 ニューロジェン・コーポレーション Ｃ５ａ受容体モジュレータである新規なアリールイミダゾール及び関連化合物。
US7728009B1 (en) * 2005-02-18 2010-06-01 Neurogen Corporation Thiazole amides, imidazole amides and related analogues

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3362956A (en) * 1965-08-19 1968-01-09 Sterling Drug Inc 1-[(heterocyclyl)-lower-alkyl]-4-substituted-piperazines
US3491098A (en) * 1967-05-29 1970-01-20 Sterling Drug Inc 1-((imidazolyl)-lower-alkyl)-4-substituted-piperazines
GB1341375A (en) * 1969-11-19 1973-12-19 Smith Kline French Lab Aminoalkylimidazoles and process for their production
EP0081324A2 (fr) * 1981-12-04 1983-06-15 Farmos Group Ltd. Dérivés substitués d'imidazole avec activité pharmacologique, leur préparation et utilisation
FR2575469A1 (fr) * 1984-12-27 1986-07-04 Synthelabo N-imidazolylmethyl-diphenylazomethines, leur preparation et leur application en therapeutique
EP0241053A1 (fr) * 1986-02-27 1987-10-14 Duphar International Research B.V (N-Pipéridinyl)-méthyl-et(N-pipérazinyl)-méthylazoles substitués par un groupes aryle et ayant des propriétés antipsychotiques
EP0289227A1 (fr) * 1987-04-24 1988-11-02 Syntex Pharmaceuticals Ltd. Dérivés substitués d'imidazolyl-alkyl-pipérazines et -diazépines
WO1989010360A1 (fr) * 1988-04-18 1989-11-02 Cedona Pharmaceuticals B.V. PROCEDE POUR PREPARER UN 4(5)-(omega-AMINOALKYLE)IMIDAZOLE SUBSTITUE OU NON SUBSTITUE

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2532547A (en) * 1950-12-05 Z-aminoalkyl-glyoxaline derivatives
US2744899A (en) * 1951-03-02 1956-05-08 Ciba Pharm Prod Inc 4-(beta-substituted aminoethyl)-imidazoles and the preparation thereof
GB1077173A (en) * 1965-03-19 1967-07-26 American Cyanamid Co Substituted alkylene piperidines and methods of preparation thereof
US4404387A (en) * 1980-09-17 1983-09-13 The Upjohn Company Aminoalkyl-substituted imidazoles
US4329470A (en) * 1981-05-04 1982-05-11 Merrell Dow Pharmaceuticals Inc. 5-(4-Phenyl 1-piperidinyl)methyl-2,3-dihydro-2-oxo-1H-imidazole-4-carboxylic acid derivatives
US4357341A (en) * 1981-05-22 1982-11-02 The United States Of America As Represented By The Department Of Health And Human Services Specific irreversible antagonism of histamine receptors by photoaffinity actuated compounds
IT1230703B (it) * 1989-01-26 1991-10-29 Luso Farmaco Inst Derivati imidazolonici ad attivita' antiipertensiva, loro metodi di preparazione e composizioni farmaceutiche che li contengono.
US5274095A (en) * 1989-05-31 1993-12-28 Boehringer Mannheim Gmbh Diarylimidazoles
US5248689A (en) * 1989-11-06 1993-09-28 Smithkline Beecham Corporation Substituted N-(imidazolyl)alkyl alanine derivatives
US5159083A (en) * 1990-12-28 1992-10-27 Neurogen Corporation Certain aminomethyl phenylimidazole derivatives; a class of dopamine receptor subtype specific ligands
US5296493A (en) * 1991-05-23 1994-03-22 Neurosearch A/S 1-substituted-2-(N-phenyl-N-(phenylmethyl)methanamine)-4,5-dihydro-imidazoles and related compounds and their use in treating calcium overload in brain cells

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3362956A (en) * 1965-08-19 1968-01-09 Sterling Drug Inc 1-[(heterocyclyl)-lower-alkyl]-4-substituted-piperazines
US3491098A (en) * 1967-05-29 1970-01-20 Sterling Drug Inc 1-((imidazolyl)-lower-alkyl)-4-substituted-piperazines
GB1341375A (en) * 1969-11-19 1973-12-19 Smith Kline French Lab Aminoalkylimidazoles and process for their production
EP0081324A2 (fr) * 1981-12-04 1983-06-15 Farmos Group Ltd. Dérivés substitués d'imidazole avec activité pharmacologique, leur préparation et utilisation
FR2575469A1 (fr) * 1984-12-27 1986-07-04 Synthelabo N-imidazolylmethyl-diphenylazomethines, leur preparation et leur application en therapeutique
EP0241053A1 (fr) * 1986-02-27 1987-10-14 Duphar International Research B.V (N-Pipéridinyl)-méthyl-et(N-pipérazinyl)-méthylazoles substitués par un groupes aryle et ayant des propriétés antipsychotiques
EP0289227A1 (fr) * 1987-04-24 1988-11-02 Syntex Pharmaceuticals Ltd. Dérivés substitués d'imidazolyl-alkyl-pipérazines et -diazépines
WO1989010360A1 (fr) * 1988-04-18 1989-11-02 Cedona Pharmaceuticals B.V. PROCEDE POUR PREPARER UN 4(5)-(omega-AMINOALKYLE)IMIDAZOLE SUBSTITUE OU NON SUBSTITUE

Also Published As

Publication number Publication date
BR1100956A (pt) 1999-08-31
CA2098301A1 (fr) 1992-06-29
CA2098301C (fr) 2001-12-04
EP0640075A1 (fr) 1995-03-01
JP2798095B2 (ja) 1998-09-17
WO1992012134A2 (fr) 1992-07-23
US5428164A (en) 1995-06-27
JPH06504054A (ja) 1994-05-12
US5159083A (en) 1992-10-27

Similar Documents

Publication Publication Date Title
WO1992012134A3 (fr) Certains derives de phenylimidazole aminomethyle; nouvelle classe de ligands a specificite de sous-type de recepteur de dopamine
MX9702234A (es) Ciertos derivados de aminometilfenilimidazol, una clase nueva de ligandos especificos del subtipo de receptor de dopamina.
DE69133156D1 (de) Behandlung von gemütskrankheiten mit funktionellen antagonisten des glycin/nmda-rezeptorkomplexes
GB9305623D0 (en) Therapeutic agents
NZ516599A (en) 2-arylimino-2,3-dihydrothiazoles, and their use thereof as somatostatin receptor ligands
CA2205998A1 (fr) Certains derives 4-aminomethyl 2-substitues de l'imidazole et derives 2-aminomethyl 4-substitues de l'imidazole, nouvelles categories de ligands specifiques du sous-type du recepteur de la dopamine
ZA955868B (en) Substituted pyrimidine compounds and the use thereof
ID22636A (id) Zat-zat terapeutik
ATE160774T1 (de) Antipsychotische benzimidazolderivate
GEP20043303B (en) Polycycloalkylpurines as Adenosine Receptor Antagonists
ATE218576T1 (de) Phosphohalohydrine, verfahren zu deren herstellung und verwendungen
ID25856A (id) Senyawa-senyawa baru
DE59510596D1 (de) Thiadiazolverbindungen als d3 dopaminrezeptorligand
PE20001084A1 (es) Agentes farmaceuticos para el tratamiento de la enfermedad de parkinson, adhd y microadenomas
BG104357A (en) Derivatives of cyclopentene used as motiline receptor antagonists
AU2342397A (en) N-aminoalkyldibenzothiophenecarboxamides; dopamine receptor subtype specific ligands
ATE141518T1 (de) Echogene partikel, verfahren zu deren herstellung und deren verwendung
CA2132544A1 (fr) Antagonistes d'angiotensine ii utiles contre les troubles lies a une vitesse alteree de l'influx nerveux, particulierement dans le cas de la neuropathie diabetique
AU655958B2 (en) Use of quisqualate-receptor antagonists for treating Parkinson's disease
ATE197455T1 (de) 3-oxo-pyrido (1,2-a) benzimidazol-4-carboxyl und 4-oxo-azepino (1,2-a) benzimidazol-5-carboxyl derivate geeignet für die behandlung von zentralnervensystemerkrankungen
ATE402704T1 (de) Dopamin-d3-rezeptor-liganden zur behandlung von sucht
MX9603199A (es) Antagonistas de receptores a endotelina.
AU2459897A (en) Novel n-aminoalkyl-1-biphenylenyl-2-carboxamides; new dopamine receptor subtype specific ligands
NO20016255D0 (no) Kromeno[4,3,2-de]isoquinoline som potente dopamineresepter ligander
PT889044E (pt) Derivados do 5-(heteroaril)alquil-3-oxo-pirido-(1,2-a)benzimidazole-4-carboxamida (pbi) uteis no tratamento de perturbacoes do sistema nervoso central

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): CA JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU MC NL SE

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: IN PAT.BUL.19/92 UNDER PUBLISHED REPLACE "A1" BY "A2"

AK Designated states

Kind code of ref document: A3

Designated state(s): CA JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU MC NL SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2098301

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 1992903112

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1992903112

Country of ref document: EP

WWR Wipo information: refused in national office

Ref document number: 1992903112

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1992903112

Country of ref document: EP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载